Research Article
Prognostic Value of Adrenomedullin and Natriuretic Peptides in Uroseptic Patients Induced by Ureteroscopy
Table 1
Baseline characteristics of study subjects.
| | Characteristics | Control () | UUO () | value | | Group I () | Group II () | Group III () |
| | Age (years) | 41.3 ± 12.6 | 43.2 ± 12.1 | 43.3 ± 11.6 | 43.6 ± 12.8 | >0.05 | | Gender | | | | | | | Men | 50 (55.6%) | 66 (55.9%) | 73 (55.3%) | 46 (56.1%) | >0.05 | | Women | 40 (44.4%) | 52 (44.1%) | 59 (44.7%) | 36 (43.9%) | | Side | | | | | | | Left | — | 60 (50.8%) | 67 (50.8%) | 42 (51.2%) | >0.05 | | Right | — | 58 (49.2%) | 65 (49.2%) | 40 (48.8%) | | Stone site | | | | | | | Proximal ureter | — | 37 (31.4%) | 40 (30.3%) | 25 (30.5%) | >0.05 | | Mid ureter | — | 41 (34.7%) | 45 (34.1%) | 28 (34.1%) | | Distal ureter | | 40 (33.9%) | 47 (35.6%) | 29 (35.4%) | | Stone size (mm) | — | 9.2 ± 4.1 | 9.6 ± 4.5 | 10.3 ± 5.2 | >0.05 | | WBC (×109/L) | 7.1 ± 1.5 | 7.2 ± 1.6 | 6.8 ± 1.5 | 7.0 ± 1.7 | >0.05 | | ET (ng/L) | 3.6 ± 1.4 | 3.5 ± 1.2 | 3.6 ± 1.6 | 3.5 ± 1.7 | >0.05 | | CRP (mg/L) | 6.0 ± 2.2 | 5.8 ± 2.1 | 5.9 ± 2.1 | 6.2 ± 2.1 | >0.05 | | LAC (mmol/L) | 1.1 ± 0.5 | 1.2 ± 0.6 | 1.3 ± 0.6 | 1.2 ± 0.5 | >0.05 | | PCT (ng/mL) | 0.24 ± 0.13 | 0.23 ± 0.12 | 0.25 ± 0.13 | 0.22 ± 0.10 | >0.05 | | Scr (μmol/L) | 75 ± 12 | 77 ± 14 | 76 ± 13 | 74 ± 11 | >0.05 | | Ccr (mL/min) | 100 ± 10 | 101 ± 12 | 99 ± 11 | 102 ± 14 | >0.05 |
|
|
UUO: unilateral ureteral obstruction; WBC: white blood cell count; ET: endotoxin; CRP: C-reactive protein; LAC: lactate; PCT: procalcitonin; Scr: serum creatinine; Ccr: creatinine clearance.
The normal values are as follows: WBC, 4.0~10.0 × 109/L; ET, 0~10 ng/L; CRP, 0~10 mg/L; LAC, 0~2.4 mmol/L; PCT, 0~0.5 ng/mL; Scr, 53~106 μmol/L (male), 44~97 μmol/L (female); Ccr, 80~120 mL/min.
|
